Research
Translational molecular imaging and therapy
The Clinical Department of Nuclear Medicine pursues a translational research concept. In close interdisciplinary networking, relevant biological processes are identified that are particularly important for the MHH's interdisciplinary focus areas. Suitable tracers for visualizing the target structure are being tested by the chemical/pharmaceutical side. In the preclinical environment, the tracers are tested for their value and used for the molecular analysis of disease and therapy mechanisms.
Successes in the preclinical setting then contribute to testing in clinical research before the molecular imaging and therapeutic approaches are applied to improve patient care. The aim is to individually optimize the detection and treatment of various diseases, in particular of the cardiovascular and nervous systems, as well as tumor diseases.
To see the open positions for research assistants, click here.
